News
Since the city's establishment in the 1820s, Indianapolis has been a magnet for immigrants seeking opportunity and refuge.
Celestica is a strong company, with a remarkable and fortunate market position, but the valuation is now too high for strong ...
BENGALURU: The Health and Family Welfare Department has written to the Drug Controller General of India (DCGI), seeking an ...
The Howard County Board of Education is suing several Big Pharma companies for allegedly inflating insulin prices, affecting ...
Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.
1h
The Print on MSNIndia’s 1st robot-assisted cementless knee replacement at Delhi hospital. What sets the procedure apartProcedure was performed on 54-yr-old patient from Jharkhand suffering from advanced osteoarthritis and severe knee ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
21h
Zacks Investment Research on MSNWill AbbVie's Acquisition Spree Aid Pipeline Growth?AbbVie ABBV has been actively ramping up its deal-making efforts lately, thereby strengthening its pipeline. While immunology ...
Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...
A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results